ask="N/A"
ask_size="N/A"
average_daily_volume="2235730"
bid="N/A"
bid_size="N/A"
book_value="0.0720"
change="+0.0033"
change_from_200_day_moving_average="0.0462"
change_from_50_day_moving_average="0.0328"
change_from_52_week_high="-0.1416"
change_From_52_week_low="0.1134"
change_in_percent="+1.3918%"
close="0.2404"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0430"
ebitda="-16.38M"
eps_estimate_current_year="-0.0700"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.0800"
ex_dividend_date="N/A"
float_shares="230204000"
high="0.2499"
high_52_weeks="0.3820"
last_trade_date="3/6/2017"
last_trade_price="0.2404"
last_trade_size="1203"
last_trade_time="4:02pm"
low="0.2301"
low_52_weeks="0.1270"
market_capitalization="57.08M"
moving_average_200_day="0.1942"
moving_average_50_day="0.2076"
name="Rexahn Pharmaceuticals
Inc. Co"
notes="N/A"
one_year_target_price="2.5000"
open="0.2489"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+23.7956%"
percent_change_from_50_day_moving_average="+15.7734%"
percent_change_from_52_week_high="-37.0681%"
percent_change_from_52_week_low="+89.2913%"
previous_close="0.2371"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.2931"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237443000"
short_ratio="0.7200"
stock_exchange="ASE"
symbol="RNN"
volume="1406627"
weeks_range_52="0.1270 - 0.3820"
